Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Candida albicans shunt infection.

S Shapiro1, T Javed, J Mealey

  • 1Department of Neurosurgery, Indiana University Medical Center, Indianapolis.

Pediatric Neuroscience
|January 1, 1989
PubMed
Summary

Successfully treating Candida albicans shunt infections requires shunt removal and Amphotericin B. Key risk factors include serious illness and prematurity, with infection occurring during placement or via bloodstream spread.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.

Journal of neuro-oncology·1995
Same author

A case-control study of the risk of breast cancer in relation to oral contraceptive use.

American journal of epidemiology·1992
Same author

Breast cancer.

The New England journal of medicine·1992
Same author

Oral contraceptive use and risk of cutaneous malignant melanoma.

Cancer causes & control : CCC·1992
Same author

Regional changes in central nervous system thyrotropin-releasing hormone after pentylenetetrazol-induced seizures in dogs.

Neurosurgery·1992
Same author

Case-control studies of colorectal cancer mortality: is the case made for screening sigmoidoscopy?

Journal of the National Cancer Institute·1992

Area of Science:

  • Infectious Diseases
  • Neurosurgery
  • Mycology

Background:

  • Cerebrospinal fluid (CSF) shunt infections pose significant challenges, particularly those caused by fungal pathogens like Candida albicans.
  • Early and effective treatment is crucial to prevent severe neurological complications.

Observation:

  • This report details seven successful cases of Candida albicans CSF shunt infections.
  • Treatment involved shunt removal combined with intravenous Amphotericin B, and in four cases, intraventricular Amphotericin B was also administered.

Findings:

  • Major risk factors identified include serious underlying medical conditions, recent antibiotic use, indwelling catheters (intravascular or Foley), concurrent candidiasis, and premature birth with low birth weight.
  • Candida shunt infections can arise from contamination during shunt surgery or through hematogenous spread from a distant infection site.

Implications:

  • These findings highlight the importance of recognizing risk factors for Candida shunt infections in vulnerable patient populations.
  • The reported treatment regimen provides a successful model for managing these challenging infections.
  • Understanding the routes of infection (contamination vs. hematogenous) can inform preventative strategies in neurosurgical procedures.

Related Experiment Videos